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Isoprenoids are a large family of compounds with essential func-
tions in all domains of life. Most eubacteria synthesize their isopre-
noids using the methylerythritol 4-phosphate (MEP) pathway,
whereas a minority uses the unrelated mevalonate pathway and
only a few have both. Interestingly, Brucella abortus and some
other bacteria that only use the MEP pathway lack deoxyxylulose
5-phosphate (DXP) reductoisomerase (DXR), the enzyme catalyzing
the NADPH-dependent production of MEP from DXP in the first
committed step of the pathway. Fosmidomycin, a specific compet-
itive inhibitor of DXR, inhibited growth of B. abortus cells expres-
sing the Escherichia coli GlpT transporter (required for fosmidomy-
cin uptake), confirming that a DXR-like (DRL) activity exists in these
bacteria. The B. abortus DRL protein was found to belong to a fa-
mily of uncharacterized proteins similar to homoserine dehydro-
genase. Subsequent experiments confirmed that DRL and DXR
catalyze the same biochemical reaction. DRL homologues shown
to complement a DXR-deficient E. coli strain grouped within the
same phylogenetic clade. The scattered taxonomic distribution
of sequences from the DRL clade and the occurrence of several
paralogues in some bacterial strains might be the result of lateral
gene transfer and lineage-specific gene duplications and/or losses,
similar to that described for typical mevalonate and MEP pathway
genes. These results reveal the existence of a novel class of oxidor-
eductases catalyzing the conversion of DXP intoMEP in prokaryotic
cells, underscoring the biochemical and genetic plasticity achieved
by bacteria to synthesize essential compounds such as isoprenoids.
Brucella ∣ DXR ∣ fosmidomycin ∣ methylerythritol ∣ phylogenetic
Isoprenoids, one of the largest groups of natural compounds,have a variety of roles in respiration, photosynthesis, membrane
structure, allelochemical interactions, and growth regulation
(1–3). All free-living organisms synthesize isoprenoids from the
five carbon precursors isopentenyl diphosphate (IPP) and its
double-bond isomer dimethylallyl diphosphate (DMAPP). For
decades it was believed that IPP was exclusively synthesized from
acetyl coenzyme A by the mevalonate (MVA) pathway and then
converted into DMAPP by a IPP/DMAPP isomerase (IDI) en-
zyme (4). However, in the early nineties of the last century it
was discovered that IPP and DMAPP could be formed simulta-
neously from pyruvate and glyceraldehyde 3-phosphate by an
alternative route currently known as the methylerythritol 4-phos-
phate (MEP) pathway (5, 6). It is now well established that most
organisms only use one of the two pathways for isoprenoid bio-
synthesis. Thus, archaea (archaebacteria), fungi, and animals
synthesize IPP from MVA, whereas most bacteria (eubacteria)
only use the MEP pathway for the production of isoprenoid pre-
cursors. Plants employ both pathways, but in different cell com-
partments: The MVA pathway synthesizes cytosolic isoprenoid
precursors whereas the MEP pathway is located in plastids (7).
Because the MEP pathway is absent from animals (including
humans) but it is essential in a large number of major bacterial
pathogens, it has been proposed as a promising new target for the
development of novel antiinfective agents (8, 9). However, infor-
mation on possible mechanisms for resistance to a block of the
MEP pathway is scarce. Antibiotic resistance can be caused by an
active export or blocked import of the drug, by its inactivation
inside the cell, by the genetic modification of its protein target,
or by the use of an alternative pathway not affected by the inhi-
bitor, to mention just a few possibilities. The best characterized
inhibitor of the MEP pathway is fosmidomycin (FSM), first iden-
tified as a natural antibiotic effective against a wide bacterial
spectrum. FSM is a specific competitive inhibitor of deoxyxylu-
lose 5-phosphate (DXP) reductoisomerase (DXR), the enzyme
catalyzing the NADPH-dependent production of MEP from
DXP in the first committed step of the pathway (10). The uptake
of FSM by bacterial cells is an active process involving a cAMP-
dependent glycerol 3-phosphate transporter (GlpT) protein (11).
A defective glpT gene in Escherichia coli mutants or the absence
of a GlpT homologue in other bacteria such as Mycobacterium
tuberculosis leads to FSM resistance (11, 12). Overexpression
of the E. coli fsr gene, encoding a protein with similarity to
bacterial drug-export proteins, also results in FSM resistance,
likely because this protein facilitates the export of the inhibitor
(13). Furthermore, a number of independent mutations have
been shown to rescue the survival of E. coli strains defective in
the first two genes of the MEP pathway, suggesting that bacteria
can respond to a block of DXP synthase (DXS) or DXR activities
by using other enzymes that produce DXP or MEP when mutated
(14). Alternative pathways and metabolic intermediates have
been proposed to be used for the biosynthesis of isoprenoid pre-
cursors in the cyanobacterium Synechocystis PCC 6803, which
lacks the MVA pathway and does not use the MEP pathway un-
der photosynthetic conditions (15, 16). These results illustrate
how limited is still our knowledge of the alternative pathways that
can be used by bacteria to synthesize their isoprenoids. In this
context, we noticed that the completely sequenced genomes of
a number of bacteria, including the pathogenic Brucella abortus
2308 (17), contain the genes of the MEP pathway with the only
exception of that encoding DXR, suggesting that these bacteria
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may use an alternative enzyme to produce MEP. Here we report
the cloning of the gene encoding such an alternative enzyme,
demonstrate its biochemical activity both in vivo and in vitro,
and examined its phylogenetic distribution across bacteria.
Results
B. abortus Cells Expressing GlpT Become Sensitive to FSM. The com-
pletely sequenced genome of B. abortus lacks a DXR-encoding
gene but it contains homologues of the rest of MEP pathway
enzymes (Fig. 1 and Table S1). This suggests that a B. abortus
protein showing no overall homology to DXR might be involved
in transforming DXP into MEP. However, growth of B. abortus
cells was not inhibited by concentrations of FSM up to 1 mg∕
mL. This result suggested that the putative DXR-like (DRL) en-
zyme might not be inhibited by FSM or, alternatively, that the
inhibitor was degraded, expelled, or not taken by living cells. Con-
sistent with the last possibility, the B. abortus genome contains a
fsr gene (BAB1_0676) but no glpT homologue. To investigate
whether a defective uptake of FSM was the cause of the resis-
tance phenotype of this bacterium, the E. coli gene encoding
the GlpT transporter was expressed in B. abortus cells. As shown
in Fig. S1, transformants became FSM sensitive with a minimal
inhibitory concentration of 4 μg∕mL, confirming that the resis-
tance phenotype of wild-type cells resulted solely from the
absence of an appropriate uptake mechanism. These data also
suggested that the activity of the putative B. abortusDRL protein
was actually inhibited by FSM, consistent with the hypothesis that
the biochemical mechanism used by this alternative enzyme to
produce MEP from DXP might be similar to that used by DXR.
Complementation of E. coli Strains Defective in DXR Leads to the Iden-
tification of DRL.To identify the gene encoding DRL in B. abortus,
we constructed a genomic library of this bacterium and used it to
complement a DXR-deficient E. coli mutant. The genome of
E. coli strain EcAB4-10 harbours a deletion of the dxr gene
and a synthetic MVA operon that allows the production of
IPP and DMAPP (and therefore the survival of the cells) when
MVA is supplied to the growth medium (14). Competent EcAB4-
10 cells were transformed with the B. abortus genomic library and
plated in the absence of MVA. Plasmids from positive transfor-
mants that grew without exogenous MVA were sequenced and
shown to contain overlapping B. abortus genomic fragments con-
taining the genes BAB2_0264 and BAB2_0265 (Fig. S2A).
BAB2_0265 codes for a hydrolase whereas BAB2_0264 codes
for a protein annotated as a putative oxidoreductase (a family
that includes DXR) and was therefore selected for further experi-
ments. Transformation of EcAB4-10 cells with a vector harbour-
ing only BAB2_0264 led to full complementation of MVA
auxotrophy (Fig. 2), suggesting that the encoded protein
(Q2YIM3) was the predicted B. abortus DRL enzyme. The same
construct was used in complementation experiments with the E.
coli strains EcAB4-2 and EcAB4-7, defective in DXS and MEP
cytidylyltransferase (MCT) activities respectively (14). As shown
in Fig. 2, expression of BAB2_0264 in these strains did not rescue
their MVA auxotrophy. These results are strong in vivo evidence
that this gene encodes a DXR-like enzyme that requires a supply
of DXP (or a derived metabolite synthesized by DXS) to produce
MEP (or a precursor that could be transformed into MEP or used
by MCT activity) for isoprenoid biosynthesis (Fig. 1).
DRL and DXR Catalyze the Same Biochemical Reaction.The identified
B. abortusDRL protein sequence showed no overall homology to
DXR but to homoserine dehydrogenase (HD) enzymes (18). A
search for functional domains detected the existence of an N-
terminal NAD(P)-binding domain (Fig. S2B) arranged forming
a modified Rossman fold similar to that found in numerous de-
hydrogenases. This, together with the in vivo results (Fig. 2 and
Fig. S1), suggested that DRL might use NADPH to catalyze a
reaction very similar (or even identical) to that catalyzed by
DXR. To verify this possibility, a recombinant DRL protein fused
to a polyhistidine tail was produced in E. coli and purified
(Fig. S3) to be used in in vitro DXR activity assays. Control assays
were performed with recombinant DXR protein from E. coli, and
the reaction products were analyzed by UPLC-MS(/MS). Sam-
ples containing either DRL or DXR were found to produce
MEP from DXP in a similar fashion (Fig. 3A). The identity of
the reaction product in the DRL sample was confirmed by com-
paring its fragmentation pattern with that of a MEP standard
(Fig. 3B). When reaction mixtures were prepared without enzyme
or without NAPDH, only peaks form∕z 213∕97 (DXP) transition
were detected (Fig. 3A). Furthermore, the activity of the recom-
binant DRL enzyme was sensitive to inhibition with FSM
(Fig. 3C). Size-exclusion chromatography (Fig. S3) showed that
the molecular weight of the active enzyme is ca. 80 kDa (i.e.,
about twice the size deduced from the protein sequence), suggest-
ing that DRL is a homodimer, like DXR (10, 19). Also similarly,
DRL activity has a pH optimum in the range 7.5–8 and a tem-
perature optimum of 40–45 °C (Fig. S4). Lineweaver–Burk plot
of enzyme parameters (Fig. S4) showed a Vmax ¼ 0.083 μmol
NADPH min−1 mg−1, a kcat ¼ 0.065 s−1, and a KmðDXPÞ ¼
109 μM for the recombinant DRL protein. Under the same ex-
perimental conditions the KmðDXPÞ for E. coli DXR was 211 μM,
of the same order as the values reported in the literature for dif-
ferent DXR enzymes (19). By contrast, the kcat values for DXR
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Fig. 1. The MEP pathway in bacteria. DXP, deoxyxylulose 5-phosphate; MEP,
methylerythritol 4-phosphate; CDP-ME, cytidine diphosphomethylerythritol;
IPP, isopentenyl diphosphate; DMAPP, dimethylallyl diphosphate. Enzymes
are indicated in bold: DXS, DXP synthase (EC 2.2.1.7); DXR, DXP reductoi-
somerase (EC 1.1.1.267); MCT, MEP cytidylyltransferase (EC 2.7.7.60). The step
inhibited by FSM is indicated. Dashed closed arrows represent several steps.
The E. coli strains defective in DXS (EcAB4-2), DXR (EcAB4-10), or MCT (EcAB4-
7) activities used here were engineered to utilize exogenously supplied MVA
for the biosynthesis of IPP (dashed open arrow). The dotted closed arrow
marks the reaction catalyzed by the DRL enzyme identified in this work.
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are between two and three orders of magnitude higher than that
calculated for the B. abortus recombinant DRL (19). Together,
DRL defines a new class of NADPH-dependent enzymes related
to HD-like oxidoreductases that catalyze the formation of MEP
from DXP almost identically to DXR, even though the rate of
conversion appears to be lower in the case of DRL.
The Distribution of DRL and DXR Sequences Is Not Mutually Exclusive
in All Organisms. BLAST searches of Universal Protein Resource
(UNIPROT) databases using the B. abortus DRL sequence
(Q2YIM3) as a query retrieved 185 hits (Table S2). Most bacteria
only had one putative DRL homologue, but 17 strains had two
and 3 strains had three (Table S1 and Table S2). When the dis-
tribution of putative DRL sequences was compared to that of
MEP pathway enzymes, three classes were established. The first
one (class A) was formed by bacteria with DRL instead of DXR
sequences in their genomes. Most of these DRL sequences (in-
cluding the B. abortus protein identified here) were from
alpha-proteobacteria, but some were also found in firmicutes
(Table S1). In particular, the single DRL sequences found in
the genomes of the alpha-proteobacterium Bartonella henselae
(Q6G2D9) or the firmicute Finegoldia magna (B0S038) were
found to be active in complementation experiments with the
EcAB4-10 strain (Table 1). The same approach confirmed the ac-
tivity of the duplicated DRL sequences present in the genome of
the alpha-proteobacteria Ochrobactrum anthropi (A6WYQ0 and
A6X6G6) and Mesorhizobium loti (Q98FT2 and Q989B6). The
second class (B) was formed by bacteria with sequences encoding
both DRL and DXR enzymes (Table S1). From these, the DRL
sequences from the alpha-proteobacteria Agrobacterium tumefa-
ciens (A9CES2) and Candidatus Pelagibacter ubique (Q1V2P9),
the beta-proteobacterium Burkholderia cepacia (B4EB12), the ac-
tinobacterium Mycobacterium smegmatis (A0QQV9), and the cy-
anobacteria Nostoc punctiforme (B2IVC2) and Anabaena
variabilis (Q3ME48) failed to rescue the loss of DXR activity in
E. coli cells (Table 1). By contrast, sequences from the alpha-
proteobacterium Roseobacter litoralis (A9HDV1) and the firmi-
cutes Listeria monocytogenes (Q723A4) and Bacillus halodurans
(Q9KES5) were shown to be active in complementation assays
(Table 1), suggesting that these organisms might have redundant
enzymes catalyzing the production of MEP. However, only the
DXR homologues from Listeria monocytogenes (Q720A5) and
Bacillus halodurans (Q9KA69) were found to complement the
EcAB4-10 mutant (Table 1 and Fig. S5). The DXR sequence
from Roseobacter litoralis (A9GU34) was found to be inactive,
likely as a consequence of the high number of amino acid changes
in positions highly conserved across functional DXR enzymes
Table 1 Complementation of the DXR-defective E. coli strain EcAB4-10 with the indicated sequences
DRL DXR
Accession Length Identity Organism (Strain) Group Class Clade C-DRL C-DXR
1 Q2YIM3 438 100 Brucella abortus 2308 Alphaproteobacteria A + + np
2 A6WYQ0 438 90 Ochrobactrum anthropi LMG3331 Alphaproteobacteria A + + np
3 A6X6G6 439 75 Ochrobactrum anthropi LMG3331 Alphaproteobacteria A + + np
4 Q98FT2 442 73 Mesorhizobium loti MAFF303099 Alphaproteobacteria A + + np
5 Q989B6 433 67 Mesorhizobium loti MAFF303099 Alphaproteobacteria A + + np
6 Q6G2D9 445 65 Bartonella henselae str Houston Alphaproteobacteria A + + np
7 A9HDV1 443 62 Roseobacter litoralis Och 149 Alphaproteobacteria B + + −
8 Q9KES5 439 43 Bacillus halodurans C-125 Firmicutes B + + +
9 Q723A4 416 40 Listeria monocytogenes F2365 Firmicutes B + + +
10 B0S038 430 33 Finegoldia magna ATCC 29328 Firmicutes A + + np
11 B2IVC2 437 36 Nostoc punctiforme PCC 73102 Cyanobacteria B − − nt
12 Q3ME48 437 35 Anabaena variabilis PCC 7937 Cyanobacteria B − − nt
13 A9CES2 489 35 Agrobacterium tumefaciens C58 Alphaproteobacteria B − − nt
14 Q1V2P9 430 29 Candidatus Pelagibacter ubique HTCC1002 Alphaproteobacteria B − − nt
15 A0QQV9 454 32 Mycobacterium smegmatis mc(2)155 Actinobacteria B − − nt
16 B4EB12 442 27 Burkholderia cepacia J2315 Betaproteobacteria B − − nt
Identity values (%) are relative to the B. abortus DRL protein (Q2YIM3). Class column indicates whether sequences similar to both DRL and DXR (class B) or
only to DRL but not to DXR (class A) are present in the genome of the same strain. Clade column indicates the sequences belonging (þ) or not (−) to the DRL
clade shown in Fig. 4. C-DRL column indicates the DRL sequences complementing (þ) or not (−) the DXR-defective E.coli strain. C-DXR column indicates the
DXR sequences complementing (þ) or not (−) the DXR-defective E.coli strain; np, DXR sequence not present in the genome; nt, DXR sequence not tested in
complementation experiments.
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Fig. 2. Complementation of mutant E. coli strains with the B. abortus gene
encoding DRL. E. coli strains defective in DXR (EcAB4-10), DXS (EcAB4-2), or
MCT (EcAB4-7) activities were transformed with a plasmid expressing the
BAB2_0264 gene (DRL). Control experiments were made with plasmids for
the expression of the E. coli genes encoding DXR, DXS, or MCT (33), as well
as empty vectors (Ø). Ability of the cloned gene to rescue growth of the cor-
responding mutant strains was ascertained by streaking single colonies on
plates either supplemented (þ) or not (−) with 1 mM MVA as indicated.
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(Fig. S6). These results indicate that some class B strains are func-
tionally equivalent in terms of the MEP pathway to those in class
A (i.e., have an active DRL enzyme but lack DXR activity). A
third class (C) was formed by bacteria with DRL but no MEP
pathway enzymes. This group included archea and bacteria that
do not use the MEP pathway for isoprenoid biosynthesis
(Table S1).
DRL Homologues Cluster in a Monophyletic Group. When putative
DRL amino acid sequences resulting from BLASTsearches were
subjected to Maximum Likelihood (ML) phylogenetic analysis,
all DRL sequences shown to be active in complementation ex-
periments could be grouped in a clade (Fig. 4). Sequence identity
of the proteins within the DRL clade ranged from 33–100%
(Table S2). The DRL clade was supported by relatively low
bootstrap values (64), but was consistently retrieved through
two additional independent phylogenetic reconstruction methods
[Neighbor Joining (NJ) and Maximum Parsimony (MP)]. All the
organisms from class A had at least one DRL sequence from this
clade (Table S1). The only exception was protein B5J045 from the
strain 307 of the alpha-proteobacterium Octadecabacter antarcti-
cus. However, a DRL sequence belonging to the clade (B5K941)
was found in the genome of strain 238 (Table S1). Chloroflexus
aurantiacus (chloroflexi) was the only class C organism harbour-
ing a sequence from the DRL clade (Table S1). The rest of se-
quences in the DRL clade were from organisms belonging to
class B (i.e., also had a DXR sequence in their genomes although
not necessarily encoding an active DXR enzyme; Table 1). Most
of these organisms were firmicutes but sequences from the alpha-
proteobacterium Roseobacter litoralis, the beta-proteobacterium
Verminephrobacter eiseniae and the marine actinobacterium
PHSC20C1 were also included in the clade (Fig. 4 and Table S1).
All the sequences tested from class B organisms that were not
included in the DRL clade failed to complement the EcAB4-
10 strain (Table 1), indicating that they were not true DRL
enzymes. Taken together, these results strongly suggest that se-
quences showing identity to DRL but excluded from the DRL
clade might not be functional DRL enzymes. Although some re-
sidues and short motifs are only found in active DRL sequences
(Fig. S2B), future work will be necessary to ascertain their impor-
tance for enzymatic activity.
Discussion
Phylogenetic analyses suggest that eukaryotes have inherited
their pathways for IPP and DMAPP production from prokaryotes
(20, 21). These studies proposed that the MVA pathway is
germane to archaea (where it is required for the production of
membrane ether-linked isoprenoid lipids) whereas the MEP
pathway is the ancestral route in bacteria, serving for the produc-
tion of precursors for quinones, carotenoids, and membrane
stabilizers such as hopanoids. Although the majority of bacteria
exclusively use the MEP pathway for IPP and DMAPP biosynth-
esis, there are some exceptions (20–22). For example, several spe-
cies of parasitic Rickettsia andMycoplasma bacteria have no genes
encoding enzymes of the MVA or the MEP pathway, probably
because they obtain their isoprenoids from host cells. Some bac-
teria have been confirmed to use theMVA pathway instead of the
MEP pathway for IPP and DMAPP synthesis, whereas others
possess the two full pathways (21–24). Strikingly, related species
may use different pathways for isoprenoid biosynthesis as well as
unrelated bacteria may use the same pathway. Here we show that
some bacteria that synthesize their isoprenoids by the MEP path-
way do not use DXR but DRL, either because they lack a copy of
DXR in their genomes (those belonging to class A) or because
their DXR sequence is not functional (such as that of Roseobacter
litoralis; Table 1). Other class B strains might use both DXR and
DRL (Table 1). Interestingly, some bacteria such as Listeria
monocytogenes have complete and functional MVA and MEP
pathways (24), including an active DXR protein, and additionally
possess an active DRL enzyme (Table 1). Others such as Chloro-
flexus aurantiacus, which only uses the MVA pathway, might have
a functional DRL (A9W9R9) as deduced for its position in the
DRL clade (Fig. 4). Although functional DRL sequences have
been mainly found in groups of alpha-proteobacteria and firmi-
cutes, isolated instances of likely active DRL enzymes (as de-
duced by their grouping within the DRL clade) can be found
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Fig. 3. Biochemical characterization of a recombinant DRL protein. (A) MRM
chromatograms of a reaction mixture containing MgCl2, DTT, NADPH, and
DXP before (0 h) and 2 h after adding recombinant DRL. (Lower) Result after
incubation for 2 h with either no enzyme or purified DXR instead of DRL.
Peak 1 corresponds to DXP (m∕z 213∕97, 9.15 min). Peak 2 corresponds to
MEP (m∕z 215∕97, 9.90 min), as demonstrated by comparing its mass spectra
with that of a MEP standard (B). (C) Changes in NADPH levels monitored by
absorbance at 340 nm in reaction mixtures like those described in (A) after
adding recombinant DRL (circles). The DXR inhibitor FSMwas incorporated in
the mixtures at the indicated concentration (μM). A control without DXP
(white squares) is shown.
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in specific beta-proteobacteria, chloroflexi, and actinobacteria
strains (Table S1). The scattered distribution of genes from both
the MVA and the MEP pathways observed in living organisms
was explained as a result of lateral gene transfer (LGT) among
eukaryotes, bacteria, and archaea (20, 21). The outstanding dis-
continuity found in DRL distribution might be also explained by
LGToccurring at different times during bacterial evolution (25).
Further support for LGT as the most parsimonious explanation
for the patchy distribution of DRL enzymes is provided by the
discrepancy between DRL-based phylogenetic trees and organ-
ism phylogenies. Subsequent gene duplication and/or loss in
specific bacterial evolutionary lineages might also have contri-
buted to shape the puzzling phylogenetic distribution of DRL.
The use of alternative enzymes for the same biosynthetic step
is not new in the isoprenoid field. For example, the interconver-
sion of the universal IPP and DMAPP precursors is catalyzed by
two types of IDI enzymes in bacteria: type I (similar to that found
in animals, fungi, and plants) and type II, an unrelated enzyme
(26). Although IDI activity is only essential in organisms that rely
exclusively on the MVA pathway for IPP synthesis, a recent
phylogenetic analysis found that many bacteria using the MEP
pathway possess either a type I or a type II isomerase, whereas
some bacteria have both (22). Similar to that proposed for bac-
teria with both type I and type II IDI enzymes, the presence of
different enzymes catalyzing the conversion of DXP into MEP in
the same organism (as it is the case of DXR and DRL in the fir-
micutes Listeria monocytogenes or Bacillus halodurans; Table 1)
might confer an advantage in critical situations where isoprenoid
biosynthesis is absolutely required. The existence of other class B
organisms with a nonfunctional copy of any of those two enzymes
would imply that such redundancy is not always favored, resulting
in the mutation and inactivation of either DRL or DXR in that
particular strain. This scenario provides an invaluable natural
model to examine the evolutionary mechanisms responsible for
the co-occurrence of homologous and nonhomologous genes
encoding functionally redundant enzymes. All together, these re-
sults underscore the biochemical and genetic plasticity achieved
by bacteria to synthesize essential compounds such as isopre-
noids, a crucial point that should be further investigated before
considering theMEP pathway as a convenient target for new anti-
infective drugs.
Materials and Methods
Bacterial Strains, Media, and Reagents. The Brucella abortus 2308 strain was
grown in Brucella broth or Brucella agar plates (Pronadisa). Escherichia coli
strainswere grown in LB broth or plates.When indicated, the growthmedium
was supplementedwith different concentrations of fosmidomycin (Molecular
Probes) or 1 mM MVA prepared as described (27). Unless stated otherwise,
chemicals and reagents were obtained from Sigma–Aldrich. Restriction
enzymes and DNAmodifying enzymes were purchased from Promega. Oligo-
nucleotides were synthesized by Sigma–Aldrich, and are shown in Table S3.
Construction and Screening of a B. abortus Library.GenomicDNAwasextracted
fromB. abortus 2308 cells as previously described (28). Following partial diges-
tionwith Sau3A, fragments ranging from3–6kbweregel-purified and ligated
intopUC19previouslydigestedwithBamHIanddephosphorilated.Theligation
mixturewas transformed intoE. coliDH5αandplated inLBmediumcontaining
100 μg∕mL ampicillin to amplify the library. Plasmid DNA was obtained from
cells scrapped from the plates and pooled. For the screening, 1 μg of this
DNAwas electroporated into the DXR-defective EcAB4-10 strain and transfor-
mants were selected on LB plates supplemented with 20 μg∕mL chloramphe-
nicol (to select for the disruption of the dxr gene), 25 μg∕mL kanamycin
Fig. 4. Phylogenetic analysis of putative
DRL homologues. Unrooted ML phyloge-
netic tree depicting evolutionary relation-
ships among DRL sequences resulting
from BLAST searches with B. abortus DRL
as a query (Table S2). Sequences comple-
menting the E. coli EcAB4-10 strain are indi-
cated with a black circle, whereas those that
do not complement the mutant are indi-
cated with a white circle. The letter inside
the circles indicates whether the sequence
belongs to an organism from class A (lack-
ing a DXR sequence) or class B (harbouring
a DXR sequence). The DRL clade grouping
all active DRLs is highlighted.
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(to select for the presence of the MVA operon) and 100 μg∕mL ampicillin (to
select for the incorporation of library plasmids). Plasmids isolated from
transformants were sequenced to check the identity of the inserts.
Cloning of DRL Sequences and Complementation Assays. Genomic DNA from
bacteria containing putative DRL sequences was PCR-amplified with the sets
of oligonucleotides described in Table S3. DNA fragments of the expected
size were purified and analyzed by restriction enzyme digestion to confirm
their identity. Positive fragments were cloned into pJET1.2 (Fermentas). Plas-
mid DNA from two independent clones of each construct was used to trans-
form E. coli EcAB4-10 cells. The cloned fragments were considered to encode
functional DRL enzymes when they allowed growth of transformant EcAB4-
10 cells in the absence of MVA. When indicated, E. coli strains EcAB4-2 and
EcAB4-7 were also used for complementation assays as described (14).
Production of Recombinant B. abortus DRL Protein. Oligonucleotides
DRL_NdeI.F and DRL_XhoI.R (Table S3) were used to amplify BAB2_02264
without the stop codon from B. abortus 2308 genomic DNA. The amplified
DNA fragment was cloned into the expression vector pET23b (Novagen) after
digestion with NdeI and XhoI. Following transformation of E. coli BL21(DE3)
pLys cells with the resulting construct (pET-DRL), the production of a chimeric
DRL protein with a C-terminal tag of six histidine residues was induced by
adding 0.4 mM IPTG to cultures with an OD600 ¼ 0.5. After growth for
14 h at 28 °C, bacterial cells were recovered by centrifugation and the recom-
binant DRL protein was purified as described in SI Materials and Methods.
Fractions containing DRL were pooled and stored at −20 °C in 50% glycerol.
Biochemical Characterization of the B. abortus DRL Enzyme. The purified
B. abortus DRL protein was assayed for potential DXR activity as follows. Re-
action mixtures were prepared with 15 μg of recombinant DRL in 100 mM
Tris-HCl pH 7.5, 2 mM MgCl2, 1 mM DTT, 0.78 mM DXP (Echelon), and
1 mM NADPH. Control reactions were prepared with either 15 μg of recom-
binant E. coli DXR protein or water. After incubation at 37 °C for 2 h, samples
were diluted 2∶1 with water and analyzed by ultraperformance liquid chro-
matography coupled to mass spectrometry (UPLC-MS) in tandem mode as
described in SI Materials and Methods. For the FSM inhibition assay and
calculation of kinetic parameters, DXR activity was monitored by the change
in absorbance at 340 nm as NADPH was oxidized.
Sequence and Phylogenetic Analysis. Genes encoding isoprenoid biosynthetic
enzymes were retrieved using the genomic BLAST tool at the National Center
for Biotechnology Information database. BLAST searches for putative DRL se-
quences were performed in the UNIPROT database. Only hits returning scores
corresponding to E-values <0.001 were considered significant. Phylogenetic
analyses were performed from protein sequence alignments obtained with
CLUSTALW (29) by theML, NJ, andMPmethods. ML analyses were performed
in PHYML v2.4.5, using the Jones, Taylor, and Thornton model of protein evo-
lution (30, 31). NJ and MP were implemented in MEGA 4.0, using the default
settings (32). To provide statistical confidence for the retrieved topology, a
bootstrap analysis with 1,000 replicates was performed in each case.
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